📰 Directed Issue News
Page 3 - Directed Issue News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Directed Issue. Real-time updates on events, politics, business and more.
February 20, 2023
Investegate announcements from Bavarian Nordic A/S, Bavarian Nordic A/S Launches Offering of up to 7,046,839 New Shares in a Directed Issue
February 20, 2023
Investegate announcements from Bavarian Nordic A/S, Bavarian Nordic A/S Announces Completion of Directed Issue of 7,046,839 New Ordinary Shares
February 15, 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / February 15, 2023 / Hilbert Group (STO:HILB-B)(FRA:999)THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION IN
February 14, 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / February 14, 2023 / Hilbert Group (STO:HILB-B)(FRA:999) THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLICATED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION IN
December 8, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN OR ANY OTHER JURISDICTION
December 8, 2022
/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...
December 8, 2022
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE...
December 7, 2022
STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a...
December 7, 2022
/PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs),...
December 7, 2022
STOCKHOLM, Dec. 7, 2022 /PRNewswire/ -- Vicore Pharma Holding AB (publ) ("Vicore" or the "Company"), a pioneer in the development of angiotensin II type 2 receptor agonists (ATRAGs), announces